Updates

March 1, 2021March 1, 2021
Myd88 Protein Works in Distinct Ways Within Primary Sjögren’s, Mouse Study Shows

Production of Myd88, a protein associated with autoimmune diseases, in distinct types of cells mediates different characteristics of primary Sjögren’s syndrome, a study in mouse models of ... Read more
February 22, 2021February 22, 2021
Gastrointestinal Issues Common in Primary Sjögren’s, Pilot Study Reports

Most patients with primary Sjögren’s syndrome experience gastrointestinal problems but have no recommended treatments available due to lack of information about the underlying causes, a ... Read more
February 15, 2021February 15, 2021
Specific Protein in Tears May Better Diagnose Sjögren’s

The amount of a protein called ATG5 in tears may pinpoint people whose dry eye symptoms are related to Sjögren’s syndrome with greater accuracy than ... Read more
February 11, 2021February 11, 2021
FDA Grants Priority Review to Esbriet for Unclassifiable Interstitial Lung Disease

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review to an application for Esbriet (pirfenidone) as a treatment for unclassifiable interstitial ... Read more
February 8, 2021February 8, 2021
Arthritis Medicine Tocilizumab Treats COVID-19 in Elderly Patient

Tocilizumab, a medicine approved for certain types of arthritis, may be a safe and effective approach for treating severe respiratory distress associated with COVID-19 in people ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

May 22, 2018

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome

News

Researchers recently identified an autoantibody — an antibody produced against a person’s own tissue or molecule — significantly associated with the peripheral nerve damage common in Sjögren’s syndrome patients. This finding may help scientists understand the cause and development of peripheral ... Read more

Updates

Myd88 Protein Works in Distinct Ways Within Primary Sjögren’s, Mouse Study Shows

Gastrointestinal Issues Common in Primary Sjögren’s, Pilot Study Reports

FDA Grants Priority Review to Esbriet for Unclassifiable Interstitial Lung Disease

Arthritis Medicine Tocilizumab Treats COVID-19 in Elderly Patient

Pilocarpine Aids Saliva Flow, But Not via Changes to Gland Structure

Trial Recruiting Sjögren’s Patients to Test Sjogo Self-Management App

Sjögren’s Foundation Favors COVID-19 Vaccination for Patients

Health, Financial Impact of Acute Kidney Injury Similar With or Without Sjögren’s

Electrical Brain Stimulation Found to Safely Reduce Sjogren’s Fatigue

Higher Risk of Blood Clots With COVID-19 Infection Seen in Study

Subscribe to our mailing list

RSLV-132 Lowers Fatigue in Primary Sjögren’s Patients in Phase 2 Trial

Study Links Altered Gut Microbiome in Sjogren’s to Systemic Inflammation

Sjogren’s Foundation Welcomes Applications for 2021 Research Grants

New $100M Program Aims to Improve Diversity in Clinical Trials

Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests

LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures

Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests

Study Links Immune Regulatory Molecule NEAT1 to Primary Sjogren’s

Seletalisib Shows Trend Toward Easing Primary Sjögren’s in Phase 2 Trial

$3.7M NIH Grant Will Support Research to Pinpoint Genes Associated With Sjögren’s

Endoscopic Irrigation Brings Long-term Oral Relief to Sjögren’s Patients in Trial

Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds

Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests

Attention Deficits May Underlie Cognitive Impairment in Neuro‐Sjögren’s, Study Finds

Tumor Markers in Blood May Help Diagnose Lung Disease in Sjögren’s Patients, Study Finds

Increased Gene Activity Linked to Immune Cell Malfunction, Study Reveals

Unexplained Kidney, Neurological Problems, Fever Could Be Sjögren’s, Case Study Suggests

Saliva Levels of IL-6 Protein May Help in Diagnosing Primary Sjögren’s

Severe Dryness Symptoms Increase Risk of Cavities, Oral Candida, Study Finds

Australian Partnership to Advance Technology to Treat Sjogren’s

Luminary Therapeutics, Case Western Team Up to Develop New CAR T-Cell Therapy

Researchers Discover Two Potential Biomarkers for Primary Sjögren’s Syndrome

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome

Myd88 Protein Works in Distinct Ways Within Primary Sjögren’s, Mouse Study Shows

Gastrointestinal Issues Common in Primary Sjögren’s, Pilot Study Reports

Specific Protein in Tears May Better Diagnose Sjögren’s

FDA Grants Priority Review to Esbriet for Unclassifiable Interstitial Lung Disease

Arthritis Medicine Tocilizumab Treats COVID-19 in Elderly Patient

Pilocarpine Aids Saliva Flow, But Not via Changes to Gland Structure

Trial Recruiting Sjögren’s Patients to Test Sjogo Self-Management App

Sjögren’s Foundation Favors COVID-19 Vaccination for Patients

Health, Financial Impact of Acute Kidney Injury Similar With or Without Sjögren’s

Electrical Brain Stimulation Found to Safely Reduce Sjogren’s Fatigue

Higher Risk of Blood Clots With COVID-19 Infection Seen in Study

Subscribe to our mailing list

RSLV-132 Lowers Fatigue in Primary Sjögren’s Patients in Phase 2 Trial

Study Links Altered Gut Microbiome in Sjogren’s to Systemic Inflammation

Sjogren’s Foundation Welcomes Applications for 2021 Research Grants

New $100M Program Aims to Improve Diversity in Clinical Trials

Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests

LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures

Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests

Study Links Immune Regulatory Molecule NEAT1 to Primary Sjogren’s

Seletalisib Shows Trend Toward Easing Primary Sjögren’s in Phase 2 Trial

$3.7M NIH Grant Will Support Research to Pinpoint Genes Associated With Sjögren’s

Endoscopic Irrigation Brings Long-term Oral Relief to Sjögren’s Patients in Trial

Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds

Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests

Attention Deficits May Underlie Cognitive Impairment in Neuro‐Sjögren’s, Study Finds

Tumor Markers in Blood May Help Diagnose Lung Disease in Sjögren’s Patients, Study Finds

Increased Gene Activity Linked to Immune Cell Malfunction, Study Reveals

Unexplained Kidney, Neurological Problems, Fever Could Be Sjögren’s, Case Study Suggests

Saliva Levels of IL-6 Protein May Help in Diagnosing Primary Sjögren’s

Severe Dryness Symptoms Increase Risk of Cavities, Oral Candida, Study Finds

Australian Partnership to Advance Technology to Treat Sjogren’s

Luminary Therapeutics, Case Western Team Up to Develop New CAR T-Cell Therapy

Researchers Discover Two Potential Biomarkers for Primary Sjögren’s Syndrome